GO:1904666 regulation of ubiquitin protein ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904666 describes any process that modulates the frequency, rate or extent of ubiquitin protein ligase (E3) activity, a central control point in ubiquitin-proteasome signaling.
• E3 ligases such as NEDD4, SMURF1, UBR5, c-Cbl, COP1-DET1 and Nedd4-2 are themselves tightly regulated by phosphorylation, conformational change, complex assembly and substrate availability [1,2,3,5,6,7].
• Dysregulation of E3 ligase activity contributes to cancer, neurodegeneration, mitotic checkpoint defects and metabolic disease, making this process a major therapeutic target [3,5,6].
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect causal roles of E3 regulators in cells and organisms [1,2,3,4,5,6,7].
• High-throughput screens, proteomics, structural biology and bioinformatics are converging to map the regulatory landscape of ubiquitin ligases [2,4,5].
• EDITGENE provides end-to-end CRISPR cell model and screening services to study GO:1904666-related genes with publication-grade rigor [1,2,3,4,5,6,7].
Description
Regulation of ubiquitin protein ligase activity (GO:1904666) is a biological process that controls the frequency, rate or extent of ubiquitin protein ligase (E3) activity, thereby shaping ubiquitin signaling in cells. E3 ligases catalyze the final step of ubiquitin conjugation, and their regulation determines which substrates are modified, when, and with what ubiquitin chain topology. Because ubiquitination governs protein stability, localization and interactions, the regulation of E3 activity is central to nearly every cellular decision [1,4]. Mechanistically, E3 ligases are regulated at multiple levels, including phosphorylation-induced conformational changes, autoinhibition, allosteric activation, complex assembly with adaptors and substrate availability [4,6]. For example, c-Cbl is regulated by phosphorylation-induced conformational change and can be constitutively activated by tyrosine-to-glutamate point mutations. Similarly, NEDD4 family ligases are controlled by intramolecular interactions, calcium/calmodulin binding and phosphorylation. Understanding GO:1904666 is therefore critical for researchers in cancer biology, neurobiology, immunology and drug discovery, because perturbing E3 regulation can selectively alter disease-relevant signaling pathways [3,5,6]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links and experimental methods for studying regulation of ubiquitin protein ligase activity [1,2,3,4,5,6,7].
regulation of ubiquitin protein ligase activity At A Glance
| GO ID | GO:1904666 |
|---|---|
| GO term | regulation of ubiquitin protein ligase activity |
| Ontology | biological_process |
| Synonym | regulation of APC-fizzy related complex activity; regulation of E3; regulation of protein ubiquitination activity; regulation of ubiquitin ligase activity |
| Major function | Modulates the frequency, rate or extent of E3 ubiquitin ligase activity, thereby controlling substrate ubiquitination. |
| Key regulators | Phosphorylation, conformational change, complex assembly, adaptor proteins, substrate availability [1,4,6]. |
| Representative E3s | NEDD4, SMURF1, UBR5, c-Cbl, COP1-DET1, Nedd4-2 [1,2,3,5,6,7]. |
| Disease relevance | Cancer, neurodegeneration, mitotic checkpoint disorders, metabolic stress responses [3,5,6,7]. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, proteomics, structural biology, high-throughput screens [2,4,5]. |
What Is GO:1904666?
GO:1904666, regulation of ubiquitin protein ligase activity, is defined as any process that modulates the frequency, rate or extent of ubiquitin protein ligase activity. In practice, this includes mechanisms that activate, inhibit or tune E3 ligases, such as post-translational modifications, conformational switches, binding of regulatory subunits, and changes in subcellular localization [1,4,6].
Why Is regulation of ubiquitin protein ligase activity Important in Cell Biology?
Regulation of ubiquitin protein ligase activity is a master control node in the ubiquitin-proteasome system, determining the stability, localization and function of thousands of proteins. Because E3 ligases are the substrate-recognition components of ubiquitination, their regulation directly influences cell cycle progression, DNA repair, immune signaling, stress responses and neuronal homeostasis [1,3,6]. Consequently, aberrant regulation of E3 activity is implicated in cancer, neurodegeneration and developmental disorders, and E3 ligases are among the most pursued drug targets in biomedical research [3,5,6].
• Controls substrate specificity of ubiquitination, affecting protein half-life and signaling.
• Regulates cell cycle checkpoints and mitotic progression through complexes such as APC and UBR5.
• Modulates immune and inflammatory signaling via c-Cbl and NEDD4 family ligases [1,6].
• Influences neuronal development and degeneration through Nedd4-2 and SMURF1 [2,7].
• Plays a role in stress granule and P-body dynamics under hyperosmotic stress.
• Is dysregulated in multiple cancers, including breast, lung and colorectal cancers [5,6].
• Provides targets for small-molecule modulators of E3 activity [1,4].
• Enables synthetic lethality approaches in cancer therapy [3,5].
• Serves as a biomarker for proteasome pathway activity in metabolic studies.
• Underpins experimental models for drug discovery and target validation [2,4].
What Happens During regulation of ubiquitin protein ligase activity?
Initiation and substrate recognition
In simple terms: The E3 ligase first binds its target protein, deciding what will be tagged for degradation or signaling.
Regulation begins with substrate recognition by the E3 ligase, often mediated by adaptor proteins or substrate-binding domains. For example, SMURF1 substrates have been identified using protein microarrays, revealing specificity determinants. In c-Cbl, phosphorylation-induced conformational change exposes the substrate-binding site, enabling recognition of activated receptor tyrosine kinases.
Conformational activation and autoinhibition
In simple terms: Many E3 ligases are kept inactive by folded structures and must change shape to become active.
E3 ligases such as c-Cbl and NEDD4 are regulated by autoinhibitory intramolecular interactions that are relieved by phosphorylation or ligand binding [1,6]. Point mutations that mimic phosphorylation (e.g., tyrosine to glutamate) can constitutively activate c-Cbl, demonstrating the importance of conformational control. Structural studies of cullin-RING ligases have revealed how neddylation and adaptor exchange regulate activity.
Complex assembly and cofactor recruitment
In simple terms: E3 ligases often work in teams with other proteins that turn them on or off.
Multi-subunit E3 complexes, such as COP1-DET1, require assembly of specific subunits for activity. Cryo-EM structures of the human COP1-DET1 complex have provided mechanistic insights into how complex formation regulates ligase function. Similarly, UBR5 regulates mitotic checkpoint complexes, and its activity is coupled to complex disassembly.
Post-translational modification of E3 ligases
In simple terms: Chemical tags added to the E3 ligase itself can switch its activity up or down.
Phosphorylation, ubiquitination and neddylation of E3 ligases modulate their activity [1,4]. NEDD4 ubiquitin E3 ligase activity is regulated by phosphorylation and calcium/calmodulin binding. Nedd4-2 localization to P-bodies under hyperosmotic stress is regulated by its ubiquitin ligase activity, linking post-translational modification to subcellular dynamics.
Subcellular localization and substrate availability
In simple terms: Where the E3 ligase is in the cell and whether its targets are nearby affects how active it can be.
Regulation also occurs through changes in subcellular localization, which determine access to substrates. Nedd4-2 promotes localization of DNMBP/Tuba to P-bodies under hyperosmotic stress, illustrating how ligase activity can control compartmentalization. Additionally, substrate availability and competing interactions can tune E3 activity.
Key Genes Involved in GO:1904666 regulation of ubiquitin protein ligase activity
The following genes and proteins are central to the regulation of ubiquitin protein ligase activity, as supported by verified literature [1,2,3,4,5,6,7].
| Gene | Major Role | Research Relevance |
|---|---|---|
| NEDD4 | E3 ligase regulated by phosphorylation and calcium/calmodulin; controls substrate ubiquitination | Cancer, neuronal signaling, drug target |
| SMURF1 | HECT-type E3 ligase; substrates identified by protein microarrays | TGF-beta signaling, cancer, bone disease |
| UBR5 | E3 ligase involved in disassembly of mitotic checkpoint complexes | Mitotic regulation, cancer |
| CBL | RING E3 ligase regulated by phosphorylation-induced conformational change | Leukemia, immune signaling |
| COP1 | Component of COP1-DET1 E3 complex; structure solved by cryo-EM | Cancer, plant development |
| DET1 | Part of COP1-DET1 complex; regulates ligase activity | Cancer, developmental biology |
| NEDD4L | Nedd4-2 E3 ligase; regulates P-body localization under stress | Hypertension, metabolic stress |
| CUL1 | Scaffold of SCF E3 complex; regulated by neddylation | Cell cycle, cancer |
| RBX1 | RING finger subunit of cullin-RING ligases | Cancer, ubiquitin signaling |
| APC | Anaphase-promoting complex E3; regulated by coactivators | Mitosis, cancer |
| FBXW7 | F-box substrate receptor of SCF; regulated by dimerization | Cancer, stem cells |
| SKP1 | Adaptor in SCF complex; modulates E3 assembly | Cancer, signaling |
| CAND1 | Regulates cullin-RING ligase assembly by binding cullins | Cancer, ubiquitin dynamics |
| UBE2D1 | E2 conjugating enzyme partnering with E3s | Ubiquitin pathway research |
| DNMBP | Effector localized to P-bodies by Nedd4-2 | Stress response, cell polarity |
| MYOSTATIN | Target of ubiquitin-proteasome pathway in muscle | Muscle wasting, exercise biology |
| TRAF6 | E3 ligase regulated by oligomerization | Immune signaling, cancer |
| ITCH | HECT E3 ligase regulated by autoinhibition | Immune regulation, cancer |
How Is regulation of ubiquitin protein ligase activity Regulated?
Regulation of ubiquitin protein ligase activity is itself controlled by multiple upstream signals. Phosphorylation by kinases such as Src and Akt can activate or inhibit E3 ligases [1,6]. Calcium/calmodulin binding regulates NEDD4 family members. Neddylation of cullin-RING ligases is a key activation step, and CAND1-mediated cycles of assembly/disassembly modulate activity. Under hyperosmotic stress, Nedd4-2 activity influences P-body localization, linking environmental stress to ligase regulation. Additionally, pre-exercise feeding alters serum hormones and biomarkers of ubiquitin-proteasome pathway activity, indicating systemic metabolic regulation.
regulation of ubiquitin protein ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CBL | Leukemia, immune dysregulation | Knock-in of point mutations in CBL in hematopoietic cells |
| UBR5 | Mitotic checkpoint defects, cancer | Knockout of UBR5 in cancer cell lines |
| COP1 | Cancer, developmental disorders | Knockout or overexpression of COP1 in tumor models |
| NEDD4L | Hypertension, stress response | Knockout of NEDD4L in epithelial cells |
| SMURF1 | Bone disease, cancer | Overexpression of SMURF1 in osteosarcoma cells |
Cancer
Dysregulation of E3 ligases such as c-Cbl, COP1 and UBR5 is implicated in multiple cancers [3,5,6]. Constitutive activation of c-Cbl by point mutations can alter receptor tyrosine kinase signaling, contributing to leukemogenesis. UBR5 regulates mitotic checkpoint complexes, and its perturbation can lead to chromosomal instability. COP1-DET1 complex structures provide a basis for targeting E3 activity in cancer.
Neurodegeneration
NEDD4 family ligases regulate neuronal signaling and protein homeostasis, and their dysfunction is linked to neurodegenerative conditions. Nedd4-2 promotes localization of DNMBP/Tuba to P-bodies under stress, a process relevant to neuronal stress responses. SMURF1 substrates include proteins involved in neuronal development and degeneration.
Metabolic and muscle disorders
The ubiquitin-proteasome pathway, including E3 ligase activity, is a major determinant of muscle protein turnover. Pre-exercise feeding alters biomarkers of myostatin and ubiquitin-proteasome pathway activity, highlighting the interplay between metabolism and E3 regulation. Nedd4-2 is also implicated in hypertension and ion transport regulation.
From regulation of ubiquitin protein ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of E3 ligase X affect substrate ubiquitination? | CRISPR knockout cell line [1,2,3] |
| Does a specific phosphorylation site regulate E3 activity? | Point mutation knock-in (e.g., phospho-mimetic) |
| How does a disease-associated mutation alter E3 function? | Knock-in of patient mutation |
| Where does E3 ligase localize under stress? | Tagged knock-in with fluorescent tag |
| Does overexpression of E3 ligase drive transformation? | Overexpression cell model |
| Which substrates are regulated by E3 ligase? | Proteomics and protein microarray |
How to Study the regulation of ubiquitin protein ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on E3 activity | Target validation [1,3] |
| Point mutation knock-in | Effect of specific residues on E3 regulation | Phospho-mimetic studies |
| Overexpression | Gain-of-function phenotypes | Cancer modeling |
| Protein microarray | Substrate identification | E3 substrate profiling |
| Cryo-EM | 3D structure of E3 complexes | Mechanistic studies |
| Proteomics | Global ubiquitination changes | Pathway analysis |
| Live-cell imaging | Subcellular localization dynamics | Stress response studies |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify regulators of ubiquitin ligase activity [2,4]. These screens are powerful for discovering novel components of the ubiquitin-proteasome system and for mapping genetic interactions.
Proteomics and substrate identification
Protein microarrays and mass spectrometry-based proteomics enable unbiased identification of E3 ligase substrates and interaction partners. For example, SMURF1 substrates were identified using protein microarrays. Quantitative ubiquitin proteomics can measure changes in ubiquitination sites upon E3 regulation.
Structural biology
Cryo-EM and X-ray crystallography reveal how E3 ligases are regulated by conformational changes and complex assembly [4,5]. The cryo-EM structure of COP1-DET1 provided mechanistic insights into ligase regulation. Structural studies of cullin-RING ligases have elucidated neddylation-dependent activation.
Cell-based assays and imaging
Fluorescence microscopy and live-cell imaging can track E3 ligase localization and substrate dynamics. Nedd4-2 localization to P-bodies was visualized under hyperosmotic stress. Phospho-specific antibodies and conformational sensors can monitor E3 activation states.
How CRISPR Can Be Used to Study GO:1904666 regulation of ubiquitin protein ligase activity
Knockout
CRISPR knockout of E3 ligase genes such as NEDD4, SMURF1 or UBR5 allows researchers to assess loss-of-function phenotypes, including changes in substrate stability and cell cycle progression [1,2,3]. Knockout cell lines are essential for validating E3 ligase function in disease models.
Point Mutation
Point mutations can be introduced to mimic or abolish phosphorylation sites, such as tyrosine-to-glutamate substitutions in c-Cbl that cause constitutive activation. These models help dissect the role of specific regulatory residues in E3 activity.
Knock-in
Knock-in of disease-associated mutations or fluorescent tags enables precise study of E3 ligase regulation in a physiological context [6,7]. Tagged knock-in models allow real-time tracking of E3 localization and dynamics.
Overexpression
Overexpression of E3 ligases such as COP1 or SMURF1 can drive transformation or alter signaling, providing gain-of-function models for cancer research [2,5]. These models are useful for testing small-molecule inhibitors of E3 activity.
How EDITGENE Supports regulation of ubiquitin protein ligase activity Research
Researchers studying regulation of ubiquitin protein ligase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides publication-grade CRISPR cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for regulation of ubiquitin protein ligase activity research.
Frequently Asked Questions About regulation of ubiquitin protein ligase activity
What is GO:1904666 regulation of ubiquitin protein ligase activity?
GO:1904666 is a biological process term describing any process that modulates the frequency, rate or extent of ubiquitin protein ligase (E3) activity.
What genes are involved in regulation of ubiquitin protein ligase activity?
Key genes include NEDD4, SMURF1, UBR5, CBL, COP1, DET1, NEDD4L and others [1,2,3,5,6,7].
How is ubiquitin protein ligase activity regulated?
It is regulated by phosphorylation, conformational changes, complex assembly, cofactor binding and subcellular localization [1,4,6,7].
What diseases are linked to dysregulated E3 ligase activity?
Cancer, neurodegeneration, mitotic checkpoint defects and metabolic disorders are linked to E3 dysregulation [3,5,6,7].
What methods are used to study regulation of ubiquitin protein ligase activity?
CRISPR knockout, point mutation, knock-in, overexpression, proteomics, structural biology and high-throughput screens are commonly used [2,4,5,6,7].
What is the role of c-Cbl in ubiquitin ligase regulation?
c-Cbl is regulated by phosphorylation-induced conformational change and can be constitutively activated by point mutations.
How does NEDD4 regulate ubiquitin ligase activity?
NEDD4 is regulated by phosphorylation, calcium/calmodulin binding and autoinhibition.
What is the COP1-DET1 complex?
COP1-DET1 is a ubiquitin ligase complex whose structure has been solved by cryo-EM, revealing regulatory mechanisms.
Can CRISPR be used to study E3 ligase regulation?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to dissect E3 ligase regulation [1,2,3,6,7].
What services does EDITGENE offer for ubiquitin ligase research?
EDITGENE offers knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics [1,2,3,4,5,6,7].
Conclusion
Regulation of ubiquitin protein ligase activity (GO:1904666) is a fundamental biological process that controls E3 ligase function through phosphorylation, conformational changes, complex assembly and localization [1,4,6,7]. Its dysregulation is implicated in cancer, neurodegeneration and metabolic disease, making it a high-value target for basic and translational research [3,5,6]. CRISPR-based models and advanced screening technologies are essential tools for dissecting these mechanisms and developing new therapeutics [2,4,5].
References
- 1. Sicari D et al.. 2022. The NEDD4 ubiquitin E3 ligase: a snapshot view of its functional activity and regulation.. Biochem Soc Trans 50(1):473-485 PMID: 35129615
- 2. Andrews PS et al.. 2010. Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays.. Assay Drug Dev Technol 8(4):471-87 PMID: 20804422
- 3. Kaisari S et al.. 2022. Role of ubiquitin-protein ligase UBR5 in the disassembly of mitotic checkpoint complexes.. Proc Natl Acad Sci U S A 119(9) PMID: 35217622
- 4. Duda DM et al.. 2011. Structural regulation of cullin-RING ubiquitin ligase complexes.. Curr Opin Struct Biol 21(2):257-64 PMID: 21288713
- 5. Wang S et al.. 2026. Cryo-EM structure of the human COP1-DET1 ubiquitin ligase complex.. Nat Commun 17(1):543 PMID: 41540009
- 6. Kassenbrock CK et al.. 2004. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.. J Biol Chem 279(27):28017-27 PMID: 15117950
- 7. Liu Z et al.. 2025. The ubiquitin ligase Nedd4-2 promotes localization of DNMBP/Tuba to P-bodies under hyperosmotic stress.. J Biol Chem 301(11):110738 PMID: 40975170
- 8. Dalbo VJ et al.. 2013. Effects of pre-exercise feeding on serum hormone concentrations and biomarkers of myostatin and ubiquitin proteasome pathway activity.. Eur J Nutr 52(2):477-87 PMID: 22476926
